NAFLD independently linked to cardiovascular disease

June 7, 2012
NAFLD independently linked to cardiovascular disease
Nonalcoholic fatty liver disease is independently associated with an increased risk of cardiovascular disease, but it is not associated with a statistically significantly increased risk of cardiovascular mortality, according to a study published in the June issue of Clinical Gastroenterology and Hepatology.

(HealthDay) -- Nonalcoholic fatty liver disease (NAFLD) is independently associated with an increased risk of cardiovascular disease (CVD), but it is not associated with a statistically significantly increased risk of cardiovascular mortality, according to a study published in the June issue of Clinical Gastroenterology and Hepatology.

To examine the association between NAFLD, CVD, and , Maria Stepanova, Ph.D., and Zobair M. Younossi, M.D., M.P.H., of Inova Fairfax Hospital in Falls Church, Va., analyzed data from the National Health and Nutrition Survey III (1988 to 1994). The prevalence of CVD was assessed for 2,492 patients with NAFLD and 9,121 controls without NAFLD or other . Independent predictors of CVD and cardiovascular mortality were evaluated.

During a median of 171 months of follow-up, the researchers found cardiovascular mortality in the cohort to be 3.76 percent. Compared to controls, participants with NAFLD were older, predominantly male, less likely to be African-American, and more likely to be Hispanic. Participants with NAFLD had an increased prevalence of all components of CVD and . After adjustment for major demographic, clinical, and metabolic confounders, there was an independent correlation between NAFLD and CVD, regardless of liver enzyme levels (odds ratio, 1.23). There was no statistically significant association found between NAFLD and cardiovascular mortality.

"NAFLD is associated independently with an increased risk of CVD," the authors write. "However, NAFLD did not increase cardiovascular mortality over a 14-year period."

Explore further: Liver cancer incidence lower in patients with nonalcoholic fatty liver disease than hepatitis C

More information: Abstract
Full Text (subscription or payment may be required)
Editorial

Related Stories

Recommended for you

Heart attack treatment hypothesis 'busted'

July 6, 2015

Researchers have long had reason to hope that blocking the flow of calcium into the mitochondria of heart and brain cells could be one way to prevent damage caused by heart attacks and strokes. But in a study of mice engineered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.